Society of Toxicology
and ToxExpo
Get to clinical trial faster,
with more confidence
See how Proscia is transforming toxicologic pathology with Concentriq® LS — enhancing productivity, collaboration, and confidence from preclinical studies to regulatory submission.
Visit us in Booth 1312 to discover how we help accelerate decisions, improve research outcomes, and seamlessly integrate into your broader pharmaceutical R&D processes.
- Streamline Pathology Reviews: Purpose-built scoring workflows speed up primary and peer reviews without compromising accuracy.
- Uncover Insights with AI: AI-powered toxicity assessments reveal patterns linked to drug safety and efficacy.
- Simplify Compliance: Built-in audit logs and change tracking support GLP study requirements with ease.
- Collaborate Instantly: Real-time data sharing accelerates internal and external review cycles.
- Standardize for Efficiency: Study templates ensure consistent data capture and improve data quality.
Powering Insights
and Accelerating R&D at Every Stage
Concentriq LS is an enterprise pathology platform that helps scientists and pathologists collaborate, streamline workflows, and accelerate decision-making across R&D. Serving as a central hub for AI-enabled workflows, it unifies data, teams, and applications to unlock smarter insights. By transforming underutilized data into AI-enriched insights, Concentriq LS advances biomarker discovery, preclinical research, and clinical trials — helping organizations accelerate drug discovery and development.
LEARN MORELife sciences leaders run Concentriq LS
Concentriq LS is trusted by leading life sciences organizations, including 14 of the top 20 pharmaceutical companies,
to advance their precision medicine portfolios with pathology and AI.
Bayer: Real-Time Messaging of Pathological Diagnoses from Toxicology LIMS to Cloud-Based Digital Pathology Web Application
VIEW →About Proscia
Proscia is a software company that is accelerating pathology’s transformation toward a data-driven discipline. Our Concentriq enterprise digital pathology platform and powerful AI applications are unlocking new insights that accelerate discovery, improve patient outcomes, and fulfill the promise of precision care.